ReviewVascular health and risk management2015

Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease.

Peter P TothPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.